2018
DOI: 10.1007/978-3-319-70548-4_582
|View full text |Cite
|
Sign up to set email alerts
|

Dapagliflozin Influence on the Clinical Course of Diabetes Mellitus Type 2 and Essential Hypertension in Patients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
5
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(5 citation statements)
references
References 6 publications
0
5
0
Order By: Relevance
“…Dapagliflozin and Glucagon-like Peptide 1 Receptor Agonists (GLP-1 RAs) e.g. Liraglutide have been found to improve the efficacy of treatment and clinical course of type 2 diabetes mellitus and hypertension in patients with such comorbidities [17,22,26,31,57,58,59]. It has also been documented that coconut water has hepatorenal protective functions in alloxaninduced type 1 diabetes mellitus [13].…”
Section: Discussionmentioning
confidence: 99%
“…Dapagliflozin and Glucagon-like Peptide 1 Receptor Agonists (GLP-1 RAs) e.g. Liraglutide have been found to improve the efficacy of treatment and clinical course of type 2 diabetes mellitus and hypertension in patients with such comorbidities [17,22,26,31,57,58,59]. It has also been documented that coconut water has hepatorenal protective functions in alloxaninduced type 1 diabetes mellitus [13].…”
Section: Discussionmentioning
confidence: 99%
“…This adipose tissue itself promotes insulin resistance through various inflammatory mechanisms, including increased free fatty acids (FFAs) release and adipokine dysregulation. Lack of physical activity, prior to GDM in those with hypertension or dyslipidemia also increases the risk of developing T2DM [23,31,32,35,39,69].…”
Section: Discussionmentioning
confidence: 99%
“…Features of kidney damage in other pathological conditions such as metabolic syndrome diseases e.g. essential hypertensive disease and type 2 diabetes mellitus have been extensively studied [10,11,13,19,24,27,43]. Nevertheless, sodium-glucose linked transporter-2 (SGLT-2) inhibitors and glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have been found effective in treating patients with such co-morbid pathologies [12,16,17,21,25,48,49,50].…”
Section: Introductionmentioning
confidence: 99%
“…essential hypertensive disease and type 2 diabetes mellitus have been extensively studied [10,11,13,19,24,27,43]. Nevertheless, sodium-glucose linked transporter-2 (SGLT-2) inhibitors and glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have been found effective in treating patients with such co-morbid pathologies [12,16,17,21,25,48,49,50]. Many ecological factors (both abiotic and biotic) go a long way to influence the density, distribution and abundance of intermediate host freshwater snails [31,34].…”
Section: Introductionmentioning
confidence: 99%